Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inmune Bio (INMB) Other financing activities (2020 - 2023)

Historic Other financing activities for Inmune Bio (INMB) over the last 4 years, with Q3 2023 value amounting to $1.9 million.

  • Inmune Bio's Other financing activities fell 257.86% to $1.9 million in Q3 2023 from the same period last year, while for Sep 2023 it was $7.0 million, marking a year-over-year increase of 1655.52%. This contributed to the annual value of $4.8 million for FY2021, which is 5411.31% up from last year.
  • As of Q3 2023, Inmune Bio's Other financing activities stood at $1.9 million, which was down 257.86% from $1.9 million recorded in Q3 2022.
  • In the past 5 years, Inmune Bio's Other financing activities ranged from a high of $1.9 million in Q3 2022 and a low of $899000.0 during Q1 2021
  • Its 4-year average for Other financing activities is $1.5 million, with a median of $1.6 million in 2021.
  • Per our database at Business Quant, Inmune Bio's Other financing activities surged by 7085.65% in 2022 and then tumbled by 257.86% in 2023.
  • Over the past 4 years, Inmune Bio's Other financing activities (Quarter) stood at $1.0 million in 2020, then skyrocketed by 53.54% to $1.6 million in 2021, then increased by 20.73% to $1.9 million in 2022, then fell by 2.58% to $1.9 million in 2023.
  • Its last three reported values are $1.9 million in Q3 2023, $1.9 million for Q3 2022, and $1.5 million during Q1 2022.